473P A phase I study of E7386, a CREB-binding protein (CBP)/β-catenin interaction inhibitor, in patients with advanced solid tumors including colorectal cancer (CRC)
- Resource Type
- Abstract
- Source
- In
Annals of Oncology September 2021 32 Supplement 5:S567-S567 - Subject
- Language
- ISSN
- 0923-7534